OnTheIssuesLogo

Richard Ojeda on Drugs

 

 


Supports medical marijuana, co-founded CBD oil company

Cannabis: Ojeda is an advocate for medical marijuana and it should be noted that he does have a business interest with a CBD oil company as a co-founder.
Source: 2020 West Virginia Senate campaign website VoteOjeda.com , Jun 1, 2020

An advocate for medical marijuana

Ojeda is an advocate for medical marijuana and it should be noted that he does have a business interest with a CBD oil company as a co-founder.
Source: 2020 West Virginia Senate campaign website VoteOjeda.com , Mar 5, 2020

Marijuana can be used for clinical, medical purposes

Marijuana is one of the most popular crop around the world. Use and sell of marijuana has been prohibited in many countries due to vast notions associated with Cannabis. Marijuana can be used for clinical purposes as well as for medical purposes. The clinical use of marijuana entails prescribing the drug to patients of cancer or those who have undergone chemotherapy.
Source: 2020 West Virginia Senate campaign website VoteOjeda.com , Mar 5, 2020

Other candidates on Drugs: Richard Ojeda on other issues:
WV Gubernatorial:
Edwin Ray Vanover
Jim Justice
Michael Folk
Ron Stollings
Stephen Noble Smith
Woody Thrasher
WV Senatorial:
Carte Goodwin
Don Blankenship
Evan Jenkins
Joe Manchin III
John Raese
Patrick Morrisey
Paula Jean Swearengin
Shelley Moore Capito

WV politicians
WV Archives
Senate races 2019-20:
AK: Sullivan(R,incumbent) vs.Gross(I)
AL: Jones(D,incumbent) vs.Sessions(R) vs.Moore(R) vs.Mooney(R) vs.Rogers(D) vs.Tuberville(R) vs.Byrne(R) vs.Merrill(R)
AR: Cotton(R,incumbent) vs.Mahony(D) vs.Whitfield(I) vs.Harrington(L)
AZ: McSally(R,incumbent) vs.Kelly(D)
CO: Gardner(R,incumbent) vs.Hickenlooper(D) vs.Madden(D) vs.Baer(D) vs.Walsh(D) vs.Johnston(D) vs.Romanoff(D) vs.Burnes(D) vs.Williams(D)
DE: Coons(D,incumbent) vs.Scarane(D)
GA-2: Isakson(R,resigned) Loeffler(R,appointed) vs.Lieberman(D) vs.Collins(R) vs.Carter(D)
GA-6: Perdue(R,incumbent) vs.Tomlinson(D) vs.Ossoff(D) vs.Terry(D)
IA: Ernst(R,incumbent) vs.Graham(D) vs.Mauro(D) vs.Greenfield(D) vs.Franken(D)
ID: Risch(R,incumbent) vs.Harris(D) vs.Jordan(D)
IL: Durbin(D,incumbent) vs.Curran(R) vs.Stava-Murray(D)
KS: Roberts(R,retiring) vs.LaTurner(R) vs.Wagle(R) vs.Kobach(R) vs.Bollier(D) vs.Lindstrom(R) vs.Grissom(D) vs.Marshall(R)
KY: McConnell(R,incumbent) vs.McGrath(D) vs.Morgan(R) vs.Cox(D) vs.Tobin(D) vs.Booker(D)
LA: Cassidy(R,incumbent) vs.Pierce(D) vs.Perkins(D)

MA: Markey(D,incumbent) vs.Liss-Riordan(D) vs.Ayyadurai(R) vs.Kennedy(D)
ME: Collins(R,incumbent) vs.Sweet(D) vs.Gideon(D) vs.Rice(D)
MI: Peters(D,incumbent) vs.James(R)
MN: Smith(D,incumbent) vs.Carlson(D) vs.Lewis(R) vs.Overby(G)
MS: Hyde-Smith(R,incumbent) vs.Espy(D) vs.Bohren(D)
MT: Daines(R,incumbent) vs.Bullock(D) vs.Collins(D) vs.Mues(D) vs.Driscoll(R) vs.Giese(L)
NC: Tillis(R,incumbent) vs.E.Smith(D) vs.S.Smith(R) vs.Cunningham(D) vs.Tucker(R) vs.Mansfield(D)
NE: Sasse(R,incumbent) vs.Janicek(R)
NH: Shaheen(D,incumbent) vs.Martin(D) vs.Bolduc(R) vs.O'Brien(f)
NJ: Booker(D,incumbent) vs.Singh(R) vs.Meissner(R)
NM: Udall(D,retiring) vs.Clarkson(R) vs.Oliver(D) vs.Lujan(D) vs.Rich(R)
OK: Inhofe(R,incumbent) vs.Workman(D) vs.Broyles(D)
OR: Merkley(D,incumbent) vs.Romero(R) vs.Perkins(R)
RI: Reed(D,incumbent) vs.Waters(R)
SC: Graham(R,incumbent) vs.Tinubu(D) vs.Harrison(D)
SD: Rounds(R,incumbent) vs.Borglum(R) vs.Ahlers(D)
TN: Alexander(R,incumbent) vs.Sethi(R) vs.Mackler(D) vs.Hagerty(R)
TX: Cornyn(R,incumbent) vs.Hegar(D) vs.Hernandez(D) vs.Bell(D) vs.Ramirez(D) vs.West(D)
VA: Warner(D,incumbent) vs.Taylor(R) vs.Gade(R)
WV: Capito(R,incumbent) vs.Swearengin(D) vs.Ojeda(D)
WY: Enzi(R,incumbent) vs.Ludwig(D) vs.Lummis(R)
Abortion
Budget/Economy
Civil Rights
Corporations
Crime
Drugs
Education
Energy/Oil
Environment
Families
Foreign Policy
Free Trade
Govt. Reform
Gun Control
Health Care
Homeland Security
Immigration
Jobs
Principles
Social Security
Tax Reform
Technology
War/Peace
Welfare

Other Senators
Senate Votes (analysis)
Bill Sponsorships
Affiliations
Policy Reports
Group Ratings
 





Page last updated: Jul 30, 2020